2025. 09.24-26
上海世博展览馆1号馆&2号馆

2026. 9.1-9.3

Shanghai New InternationalExpo Center, N1-N4

Exhibition in

Days
Quality and Regulatory Conference
The 7th Edition of Regulatory Lecture: Practice for Product Compliance and Market Launch

Sep.2,2026|Conference Room E of Hall N4

Medical Device Industry Conference
Conference Agenda
09:50-10:00
Moderator Remarks
10:00-10:30
US FDA: Maintaining Regulatory Momentum in a Changing World
Mr. Wil Vargas, Public Health Advisor, FDA China Office
10:30-11:00
Latest Developments of EU MDR Regulations in 2026
Gert Bos PhD, Partner & Chief Scientific Officer (CSO), Qserve
11:00-11:30
Main Changes in the New Version of IS010993-1 and Biocompatibility Evaluation Strategies
Bill Xu, Director of Preclinical Safety Evaluation, Pharmaron Medical Devices
11:30-12:00
Implementation of Unique Device Identification (UDI) for Medical Devices and the GS1 Standards System
Su Xiaocui, Supervisor, Healthcare Application Promotion,Application Promotion Department, Article Numbering Center of China(ANCC)
12:00-12:50
Lunch & Exhibition
12:50-13:00
Moderator Remarks
13:00-13:30
Key Considerations and Design Essentials for Preclinical Animal Studies of Brain-Computer Interface Medical Devices
Zhao Jinchuan, Director of Clinical Trial Center, Dongdian(Hangzhou) Medical Technology Co., Ltd.
13:30-14:00
CMR and EDC Compliance under the EUMDR: Regulatory Requirements, Risk Assessment and Testing Strategies
Yang Zhijun, Technical Manager, SGS
14:00-14:30
Regulatory landscape in EU, updates and important timelines, Notified Body perspective on IVDR
Mikko Soikkeli, Managing Director at Sertio Oy (a Kiwa company)
14:30-15:00
Market Access for Medical Devices in Singapore, Thailand and Vietnam
Jason Zhou, Regulatory Manager, EPINTEK Medical Device CRO and Testing Center
15:00-15:30
Medical Device Registration Application and Biocompatibility Assessment
Feng Yan, Technical Director, Medical Device Division, WEIPU Group
15:30-16:00
Preclinical Animal Testing Strategies for Medical Devices and BCI Case Sharing
Yuan Hongjiang, General Manager of PharmaLegacy Diagnostic Laboratories(Shanghai) Co., Ltd.
16:00-16:10
Conference Close